Hui Dang
Compliance Officer bij Shenyang Sunshine Pharmaceuticals Co., Ltd.
Profiel
Hui Dang is currently the Director of Risk & Compliance Management at Shenyang Sunshine Pharmaceuticals Co., Ltd.
She previously worked as the Managing Director and Head of Risk & Compliance at 3SBio, Inc.
Actieve functies van Hui Dang
| Bedrijven | Functie | Begin |
|---|---|---|
Shenyang Sunshine Pharmaceuticals Co., Ltd.
 Shenyang Sunshine Pharmaceuticals Co., Ltd. BiotechnologyHealth Technology Shenyang Sunshine Pharmaceutical Co., Ltd. engages in the development and production of biological products. It offers recombinant human erythropoietin, interferon alfa 2b, interleukin 2, and thrombopoietin injections. Its business activities include research and development, and manufacture of biochemical reagents, and pharmaceutical project investment advisory services. The company was founded on January 3, 1993 and is headquartered in Shenyang, China. | Compliance Officer | 01-08-1999 |
Eerdere bekende functies van Hui Dang
| Bedrijven | Functie | Einde |
|---|---|---|
| 3SBIO INC. | Compliance Officer | - |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Beursgenoteerde bedrijven | 1 |
|---|---|
| 3SBIO INC. | Health Technology |
| Bedrijven in privébezit | 1 |
|---|---|
Shenyang Sunshine Pharmaceuticals Co., Ltd.
Shenyang Sunshine Pharmaceuticals Co., Ltd. BiotechnologyHealth Technology Shenyang Sunshine Pharmaceutical Co., Ltd. engages in the development and production of biological products. It offers recombinant human erythropoietin, interferon alfa 2b, interleukin 2, and thrombopoietin injections. Its business activities include research and development, and manufacture of biochemical reagents, and pharmaceutical project investment advisory services. The company was founded on January 3, 1993 and is headquartered in Shenyang, China. | Health Technology |
